Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Aug 01 2023

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE · · 2 pages · English

On 6ix: 6ix.com/news/press-release-aug-01-2023-12

Watch Glenmark Pharmaceuticals' latest callGlenmark Pharmaceuticals (NSE:GLENMARK) Q2 2026 Earnings Call · Replay · Nov 6Read the transcript of Glenmark Pharmaceuticals (NSE:GLENMARK) Q2 2026 Earnings Call

Release

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 01, 2023, titled "Glenmark Pharmaceuticals receives ANDA approval for Saxagliptin Tablets,2.5 mg and 5 mg".

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases